#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Extra-osseous Ewing's sarcoma Gaucher's disease type III Chronic granulomatous disease Amyotrophic lateral sclerosis Peripheral primitive neuroectodermal tumour of soft tissue Ovarian cancer Ewing's sarcoma Glioblastoma multiforme Vascular calcification Glomerulonephritis Renal cell carcinoma Ehlers-Danlos syndrome Indolent systemic mastocytosis Kidney transplant rejection Arterial tortuosity syndrome More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome – Diagnostics Phenylketonuria – Basic Information Ewing’s sarcoma recurrent – Treatment Waldenstrom’s macroglobulinaemia refractory Basal cell naevus syndrome – Basic Information Undifferentiated sarcoma – Treatment Cystic fibrosis lung Angiosarcoma metastatic – Life with Disease Mitochondrial myopathy – Basic Information Testicular leiomyosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Emraclidine Beclometasone Dipropionate Darolutamide Nefopam Hydrochloride Zopiclone Baclofen Cefixime Senicapoc HRS 9531 Topotecan Hydrochloride Anselamimab Bi 1819479 Magnesium Hst-1011 Afamelanotide Oxybuprocaine Hydrochloride Ibrutinib Alisertib Sodium Alpha1H Ptc518 More therapies…

    Learn about Your Condition

    Complicated appendicitis Diabetic gastroparesis Haematological infection Laryngeal leukoplakia Urticaria Rett syndrome Myofascial pain syndrome Bone marrow disorder Adrenocortical carcinoma Haemorrhagic stroke Progressive supranuclear palsy Pancreatic neoplasm Small for dates baby Lung adenocarcinoma stage IV Chronic myeloid leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Ficlatuzumab and Cetuximab for Adults with Recurrent or Metastatic HPV-Negative Head and Neck Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Ficlatuzumab
    • Cetuximab
    Belgium Bulgaria Czechia France Germany Hungary +5

  • Study on the Safety and Effectiveness of REGV131 and LNP1265 for Adults with Hemophilia B

    Recruiting

    2 1 1
    Investigated Drugs:
    • Adeno-Associated Virus Vector Serotype 8 Containing The Human F9 Gene
    • Messenger Rna Encoding Cas9
    • Single Guide Rna Containing A Sequence Complementary To Human Alb Locus Gene, Intron 1, Target Region
    France Germany Italy Spain

  • Study on Maximizing Methotrexate Therapy for Patients with Active Rheumatoid Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Methotrexate
    Austria Italy The Netherlands Norway Romania Sweden

  • Study of PC14586 for Patients with Advanced Solid Tumors with a Specific TP53 Mutation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Ovarian cancer
    • Breast cancer
    Investigated Drugs:
    • Pc14586
    France Germany Italy Spain

  • Study of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Dostarlimab
    Belgium Czechia France Germany Greece Hungary +7

  • Study of Patritumab Deruxtecan for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    • Patritumab Deruxtecan
    Belgium France Germany Hungary Italy The Netherlands +2

  • Study on the Effectiveness and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Nipocalimab
    • Human Normal Immunoglobulin
    Czechia France Germany Greece Italy Poland +2

  • Study Comparing MK-2870 and Pembrolizumab with Chemotherapy for Patients with Advanced Hormone Receptor Positive Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Doxorubicin Hydrochloride, Liposomal
    • H2-Receptor Antagonists
    • Buclizine Hydrochloride
    Belgium Czechia Denmark France Germany Greece +10

  • Study on Lisaftoclax and Acalabrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Zanubrutinib
    • Lisaftoclax
    • Acalabrutinib
    Belgium Bulgaria Czechia France Germany Hungary +5

  • Study on the Effects of MORF-057 for Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1
    Investigated Drugs:
    • Morf-057
    Austria Bulgaria Croatia Czechia Estonia France +8
Previous Page
1 … 22 23 24 25 26 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!